Joel Kassimir
Dermatology · New York, NYNPI 1346338480
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 71.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $4,098 and has fallen 94.3% since, to $234 in 2025.
Across 248 payments — averaging $28.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Merz North America, Inc.$644
- Revance Therapeutics, Inc.$542
- Galderma Laboratories, L.p.$327
- Aclaris Therapeutics, Inc.$158
- Pfizer$106
- plus $217 from 9 others
What the payments were for
- Consulting fees$2,82540%
- Travel & lodging$2293%
- Food & beverage$3,96857%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 172 | $5,028 |
| Merz North America, Inc. | 19 | $644 |
| Revance Therapeutics, Inc. | 7 | $542 |
| Galderma Laboratories, L.p. | 15 | $327 |
| Aclaris Therapeutics, Inc. | 17 | $158 |
| Pfizer | 5 | $106 |
| Sun Pharmaceutical Industries Inc. | 3 | $45 |
| Incyte Corporation | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Mayne Pharma Commercial LLC | 1 | $21 |
| Encore Dermatology Inc. | 1 | $20 |
| Journey Medical Corporation | 1 | $13 |
| LEO Pharma Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
| VYNE Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$3,179
- DAXXIFY$435
- XEOMIN$252
- BOTOX$150
How this compares
$7,022 in reported general payments places this provider in the 65th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Finasteride | 659 | $9,252 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 13 | $6,786 |
| Spironolactone | 367 | $5,727 |
| Clobetasol Propionate | 78 | $3,993 |
| Dutasteride | 103 | $3,730 |
| Fluorouracil | 61 | $3,728 |
| Minoxidil | 307 | $2,495 |
| ValacyclovirValacyclovir Hcl | 44 | $2,446 |
| Gentamicin Sulfate | 19 | $601 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $433 |
| Fluocinolone Acetonide | 21 | $432 |
| Doxycycline Hyclate | 30 | $261 |
| Imiquimod | 11 | $211 |
| Mupirocin | 18 | $169 |
| Ketoconazole | 11 | $143 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.